RICHTER'S TRANSFORMATION
Clinical trials for RICHTER'S TRANSFORMATION explained in plain language.
Never miss a new study
Get alerted when new RICHTER'S TRANSFORMATION trials appear
Sign up with your email to follow new studies for RICHTER'S TRANSFORMATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for patients with rare, aggressive blood cancer
Disease control Recruiting nowThis study is testing whether a drug called Glofitamab works better alone or when combined with other cancer drugs to treat Richter's Transformation. This is a fast-growing lymphoma that can develop in people with chronic lymphocytic leukemia. About 70 adults with this condition …
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Christine Ryan • Aim: Disease control
Last updated Apr 01, 2026 14:40 UTC
-
Experimental drug tested for aggressive cancer transformation
Disease control Recruiting nowThis study is testing whether an experimental drug called ONO-4538 can help control Richter's transformation, an aggressive cancer that develops in some patients with chronic lymphocytic leukemia. The trial will enroll 14 patients who have already tried other treatments without s…
Matched conditions: RICHTER'S TRANSFORMATION
Phase: PHASE2 • Sponsor: Ono Pharmaceutical Co. Ltd • Aim: Disease control
Last updated Mar 12, 2026 13:52 UTC
-
Massive 8,000-Patient study tracks rare blood cancers for decades
Knowledge-focused Recruiting nowThis study is creating a long-term registry to track 8,000 patients with several rare types of leukemia and lymphoma. It aims to collect health information over many years to understand how these diseases progress, how treatments affect long-term survival, and what late side effe…
Matched conditions: RICHTER'S TRANSFORMATION
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:37 UTC